Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study
Nützlichkeit von sepsisinduzierter Koagulopathie unter den Diagnosekriterien der disseminierten intravasalen Gerinnung: multizentrische retrospektive Validierungsstudie
Thrombosis and Haemostasis · 01.12.2025 · 125 (12) · 1240-1248
DOI: 10.1055/a-2530-7553 ↗Auf einen Blick
Bei 1.438 Sepsispatient:innen identifizierten SIC- und JAAM-DIC-Kriterien am Tag 1 fast alle ISTH-DIC-Fälle. Prognose und Outcomes waren zwischen beiden Kriterien ähnlich.
Fragestellung
Überlappen die SIC-Diagnosekriterien mit den JAAM-DIC-Kriterien bei der Identifikation von ISTH-DIC, und haben die so diagnostizierten Patient:innen die gleiche Prognose?
Methode
Multizentrische retrospektive Studie mit Sepsispatient:innen; Vergleich von SIC und JAAM-DIC an Tag 1 und 4; Referenzstandard war ISTH-DIC.
Ergebnisse
Tag 1: JAAM-DIC erkannte 98 % und SIC 94 % der ISTH-DIC-Fälle. Vorhersage von ISTH-DIC an Tag 4: AUC 0,740 vs. 0,752; MODS: AUC 0,686 vs. 0,697. Keine Unterschiede bei Überleben oder sekundären Outcomes.
Schlussfolgerung der Autor:innen
SIC- und JAAM-DIC-Diagnosen waren bei Sepsispatient:innen gleichwertig; die SIC-Kriterien fügen den aktuellen DIC-Scoring-Systemen wenig hinzu.
Kernaussagen
- SIC und JAAM-DIC erkannten fast alle ISTH-DIC-Fälle an Tag 1
- AUC für ISTH-DIC und MODS war bei beiden Kriterien ähnlich
- Keine Unterschiede in Überleben oder sekundären Outcomes
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.12.2025. Verfasst von Satoshi Gando und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sappo…. Hauptthemen laut MEDLINE: Disseminated Intravascular Coagulation, Sepsis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: JSPS KAKENHI, Japan Blood Products Organization.
Themen: Sepsis
Abstract (Originalsprache)
The criteria for diagnosing sepsis-induced coagulopathy (SIC) may overlap with those of Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC). This study determined if the diagnostic criteria of SIC overlap with JAAM DIC diagnostic criteria for identifying patients with DIC according to the International Society on Thrombosis and Haemostasis (ISTH) criteria and whether the patients diagnosed with these criteria have the same prognosis. This multicenter retrospective study included patients with sepsis diagnosed using the JAAM and ISTH DIC and SIC criteria on days 1 and 4. The established ISTH DIC criteria was the reference standard for primary outcome that compared the characteristics of SIC and JAAM DIC. Secondary outcomes were multiple organ dysfunction syndrome (MODS), ventilator-free and intensive care unit–free days, and in-hospital mortality. A total of 1,438 patients were included in this study. On day 1, the JAAM DIC and SIC criteria diagnosed almost all patients with ISTH DIC (98 and 94%, respectively), predicting ISTH DIC (area under the receiver operating curve [AUC]: 0.740 versus 0.752, p = 0.523) and MODS (AUC: 0.686 versus 0.697, p = 0.546) on day 4 and progressing to ISTH DIC in the same proportion (28.6 versus 30.1%, p = 0.622). There were no differences in survival probabilities (p = 0.196) or secondary outcomes between patients diagnosed using JAAM DIC and SIC criteria on day 1. SIC and JAAM DIC diagnoses were equal among patients with sepsis, suggesting that SIC criteria add little to current DIC scoring systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
- Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
- Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
- Department of Emergency and Critical Care Medicine, Tsukuba Memorial Hospital, Tsukuba, Japan.
- Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan.
- Department of Health Services Research, Faculty of Medicine, University of Tsukuba, Japan.
ORCID-Profile: Satoshi Gando, Takeshi Wada
Förderung
- JSPS KAKENHI
- Japan Blood Products Organization
Zitieren
APA
Gando, S., Wada, T., Yamakawa, K., Abe, T., Fujishima, S., Kushimoto, S., Mayumi, T., Ogura, H., Saitoh, D., Shiraishi, A., Umemura, Y., Otomo, Y., & Japanese Association for Acute Medicine (JAAM) (2025). Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study. Thrombosis and Haemostasis, 125(12), 1240-1248. https://doi.org/10.1055/a-2530-7553
Vancouver
Gando S, Wada T, Yamakawa K, Abe T, Fujishima S, Kushimoto S, et al. Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study. Thrombosis and Haemostasis. 2025;125(12):1240-1248. doi:10.1055/a-2530-7553
BibTeX
@article{Gando2025,
author = {Gando, Satoshi and Wada, Takeshi and Yamakawa, Kazuma and Abe, Toshikazu and Fujishima, Seitaro and Kushimoto, Shigeki and Mayumi, Toshihiko and Ogura, Hiroshi and Saitoh, Daizoh and Shiraishi, Atsushi and Umemura, Yutaka and Otomo, Yasuhiro and Japanese Association for Acute Medicine (JAAM), Japanese Association for Acute Medicine (JAAM)},
title = {Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {12},
pages = {1240--1248},
doi = {10.1055/a-2530-7553}
}
EUVIMED